Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Teplice
Clinical trial register · Czechia

Clinical Trials in Teplice, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Czechia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1513 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:18 UTC
1513
Studies in scope
all four open statuses
780
Recruiting now
open to new participants
300
Lead sponsors
across recruiting studies
Top sites
Prague 1080 Brno 610 Hradec Králové 323 Olomouc 313 Ostrava 282
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Sanofi4 Novartis Pharmaceuticals3 Upstream Bio Inc.2 Hoffmann-La Roche2 Zenas BioPharma (USA), LLC1 Amgen1 UMC Utrecht1 Celgene1 Chiesi Farmaceutici S.p.A.1 Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1 Ionis Pharmaceuticals, Inc.1 Arrowhead Pharmaceuticals1 AstraZeneca1 Eagle Pharmaceuticals, Inc.1 AlgoTherapeutix1 Generate Biomedicines1 UCB Biopharma SRL1 GlaxoSmithKline1 Genexine, Inc.1
Site location
Prague1080 Brno610 Hradec Králové323 Olomouc313 Ostrava282 Pilsen117 Pardubice92 České Budějovice61 Zlín47 Nový Jičín45 Uherské Hradiště38 Liberec36 Náchod33 Ústí nad Labem33 Ostrava - Poruba32 Ostrava-Poruba32 Brandýs nad Labem30 Jihlava29 Teplice26 Hořovice24 Slaný17 Hodonín16 Kladno15 Hlučín14 Choceň14 Jindřichův Hradec14 Český Krumlov14 Rychnov nad Kněžnou13 Chlumec nad Cidlinou13 Broumov13 Havířov13 Benešov12 Krnov12 Třinec10 Mladá Boleslav9 Opava8 Klecany8 Kutná Hora7 Kralupy nad Vltavou7 Varnsdorf7 Jaroměř7 Louny7 Mariánské Lázně7 Kolín6 Havlíčkův Brod6 Jablonec nad Nisou6 Příbram6 Klatovy6 Ostrava-Vitkovice5 Bruntál5 Chomutov5 Ostrava - Vitkovice5 Frýdek-Místek5 Jílové u Prahy5 Ostrava Poruba5 Humpolec5 Hradec Kralova5 Nový Hradec Králové5 Karvina Frystat5 Praha 4 - Krc4 Karlovy Vary4 Brno-Bohunice4 Chrudim4 Litovel4 Břeclav4 Holešov4 Brandýs nad Labem-Stará Boleslav4 Tábor4 Brno-Židenice4 Přerov4 Trutnov4 Lovosice4 Kroměříž4 Poruba4 Plzen Bory4 Hradec Králove4 Nový Jiín3 Plzen Bolevec3 Bílovec3 Ostrava-poruba3 Česká Lípa3 Sokolov3 Miroslav3 Praha Klanovice3 Jilemnice3 Ledeč nad Sázavou3 Pardubice V3 Plzen - Lochotin3 New Town3 Dolní Břežany3 Kyjov3 Nymburk2 Beroun2 Havirov - Mesto2 Ostrava-Vítkovice2 Říčany2 Bohnice2 Praha 8 - Liben2 PLZE2 Motol2 Praha 5 - Motol2 Praha 8 - Libeň2 Poděbrady2 Nové Město na Moravě2 V Uvalu 842 Vodňany2 Chrudim III2 Plzen-bory2 Bílina2 Roudnice nad Labem2 Česká Třebová2 Králová2 Rokycany2 Strakonice2 Studénka2 Vsetín2 Benesov U Prahy2 Praha 4-Krc2 Nový Jicin2 Praha 1- Mala Strana2 Janske Lazne1 Ostrava - Vítkovice1 Hradec Kralove1 Jind?ich?v Hradec1 Czechia1 Plze?1 Kladruby1 Lázně Bělohrad1 Protivín1 Brno-Královo Pole1 Severomoravsky KRAJ1 Vinohrady1 Praha 8-Liben1 Multiple Locations1 Praha 8 Liben1 Brno-Vinohrady1 Vyškov1 Vítkovice1 Plzen - Bory1 Praha 2 - Nové Město1 Milovice1 Jinočany1 Ostrava- Vitkovice1 Jindichv Hradec1 Boskovice1 Měšice1 Františkovy Lázně1 Most1 Jesenice1 Praha 9 - Klánovice1 Blansko1 Borovany1 Brněnec1 Bystřice pod Hostýnem1 Čelákovice1 Česká Kamenice1 Pragues1 Brno-Zidonice1 Lomnice1 Mohelnice1 Rudná1 Velké Popovice1 Nová Ves pod Pleší1 Bedihošť1 Nový Jicín1 Phaha 51 Praha 8- Liben1 Pardubičky1 Praha 13-stodulky1 Děčín1 Praha 2 Nove Mesto1 Benátky nad Jizerou1 Havirov-Podlesi1 Bohuslavice1 Svitavy1 Prague 8 - Liben1 Moravská Ostrava1 Liberec11 Štětí1 Čáslav1 Brno-střed1 Hradec1 Znojmo1 Písek1 Jihlavska1 Prague (Praha)1 Srobarova C1 Habry1 Praha 9 - Klanovice1 Hranice1 Plzen-Bory1 Předměstí1 Sternberk1 Vestec1 Smiřice1 Ústní Nad Labem1 Plzen - Lochotín1 Pribram VIII1 Zizkova1 Pelhřimov1 Slovany1 Vysoké Mýto1 Praha1 Plzen-Lochotin1 Šumperk1 Polička1 Hostivice1 Brandys Nad Lebem1 Hradiště1 Jindrichuv Hradec III1 Police nad Metují1 Třebíč1 Ostrova1 Brno - Sever1 Plzeň 31
All 215 locations
Target enrolment
to

Trials with a site in Teplice

26 of 1513 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Czechia
Start
Recruiting
Zenas BioPharma (USA), LLC
Phase 3
705
Choceň, Hradec Králové, Teplice
2026-03-23
Recruiting
Chiesi Farmaceutici S.p.A.
Phase 2
780
Jindřichův Hradec, Louny, Lovosice, Měšice, Miroslav, Teplice, Varnsdorf
2025-12-17
Recruiting
Generate Biomedicines
Phase 3
786
Varnsdorf, Jindřichův Hradec, Prague, Jablonec nad Nisou, Teplice
2025-12-03
Recruiting
Novartis Pharmaceuticals
Phase 3
1,275
Brno, Hradec Králové, Jihlava, Prague, Teplice
2025-11-11
Active, closed
Upstream Bio Inc.
Phase 2
666
Broumov, Poruba, Prague, Rokycany, Miroslav, Brandýs nad Labem, Kralupy nad Vltavou, Teplice
2025-07-02
Recruiting
Celgene
Phase 2
200
Brno, Hradec Králové, Prague, Pardubice, Zlín, Teplice
2025-06-05
Active, closed
Upstream Bio Inc.
Phase 2
396
Teplice
2025-05-21
Active, closed
Arrowhead Pharmaceuticals
Phase 3
710
Hodonín, Hradec Králové, Náchod, Olomouc, Prague, Praha 4-Krc, Slaný, Teplice
2025-04-09
Recruiting
AstraZeneca
Phase 3
990
Brandýs nad Labem, Brno, Jindřichův Hradec, Lovosice, Pilsen, Prague, Teplice, Varnsdorf
2025-03-18
Active, closed
GlaxoSmithKline
Phase 2
307
Brandýs nad Labem, Mladá Boleslav, Teplice
2025-02-10
Active, closed
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
NCT06700343Relapsing-remitting Multiple Sclerosis (RRMS)
DrugOcrelizumab
Amgen
Phase 3
152
Brno, Hradec Králové, Jihlava, Teplice
2025-01-13
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
DrugTeriflunomide
Sanofi
Phase 3
2,500
Brno, Hradec Králové, Jihlava, Ostrava - Poruba, Pardubice, Prague, Praha 5 - Motol, Teplice
2024-04-16
Recruiting
Genexine, Inc.
Phase 3
429
Český Krumlov, Havlíčkův Brod, Pilsen, Teplice
2024-01-25
Active, closed
Sanofi
Phase 3
943
Brno, Hradec Králové, Jihlava, Ostrava, Prague, Teplice, Zlín
2023-12-27
Active, closed
Sanofi
Phase 3
1,655
Brno, Hradec Králové, Jihlava, Ostrava, Pardubice, Prague, Teplice, Zlín
2023-12-13
Active, closed
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Observational
366
Brno, Hradec Králové, Ostrava, Teplice
2023-08-03
Active, closed
Eagle Pharmaceuticals, Inc.
Phase 2
276
Teplice, Ústí nad Labem, Zizkova
2023-07-22
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Brandýs nad Labem-Stará Boleslav, Hradec Králové, Jind?ich?v Hradec, Kralupy nad Vltavou, Opava, Prague, Tábor, Teplice
2023-06-28
Active, closed
AlgoTherapeutix
Phase 2
276
Prague, Teplice
2023-02-28
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
885
Brandýs nad Labem, Hradec Králové, Louny, Náchod, Ostrava, Prague, Příbram, Teplice
2022-12-13
Active, closed
Hoffmann-La Roche
Phase 3
1,300
Brno, Havirov-Podlesi, Hradec Králové, Jihlava, Pardubice, Prague, Teplice
2022-05-03
Active, closed
UCB Biopharma SRL
Phase 3
113
Hradec Králové, Teplice
2022-02-02
Active, closed
Novartis Pharmaceuticals
Phase 3
1,007
Brno, Hradec Králové, Teplice
2021-12-13
Active, closed
Sanofi
Phase 2
129
Brno, Hradec Králové, Jihlava, Ostrava - Poruba, Teplice
2021-06-07
Active, closed
Novartis Pharmaceuticals
Phase 3
1,882
Brno, Havířov, Hradec Králové, Jihlava, Olomouc, Pardubice, Prague, Teplice
2018-12-28
Recruiting
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
NCT02735707Respiratory Tract Diseases, Influenza (Pandemic), Influenza, Community Acquired Pneumonia
DrugsConvalescent plasma·Repagermanium·Ivermectin·Telmisartan
UMC Utrecht
Phase 3
20,000
Prague, Teplice
2016-04-11
Rows per page Showing 1–26 of 26
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Czech investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-czechia/city/teplice

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Czechia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,513 studies in total at the last sync on 11 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 26 of those studies with a site in Teplice.

How many clinical trials are recruiting in Teplice?

8 of the 26 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 18 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Teplice), 26 studies
PhaseStudiesRecruitingShare
Phase 317665.4%
Phase 28230.8%
Observational103.8%

Most active sponsors

Lead sponsors with the most studies (Teplice)
Lead sponsorStudiesRecruiting
Sanofi40
Novartis Pharmaceuticals31
Hoffmann-La Roche20
Upstream Bio Inc.20
AlgoTherapeutix10
Amgen10
Arrowhead Pharmaceuticals10
AstraZeneca11
Celgene11
Chiesi Farmaceutici S.p.A.11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.